These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 18164548)

  • 1. Urokinase-type plasminogen activator receptor (uPAR) augments brain damage in a murine model of ischemic stroke.
    Nagai N; Okada K; Kawao N; Ishida C; Ueshima S; Collen D; Matsuo O
    Neurosci Lett; 2008 Feb; 432(1):46-9. PubMed ID: 18164548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroserpin, a neuroprotective factor in focal ischemic stroke.
    Cinelli P; Madani R; Tsuzuki N; Vallet P; Arras M; Zhao CN; Osterwalder T; Rülicke T; Sonderegger P
    Mol Cell Neurosci; 2001 Nov; 18(5):443-57. PubMed ID: 11922137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urokinase plasminogen activator receptor promotes macrophage infiltration into the vascular wall of ApoE deficient mice.
    Gu JM; Johns A; Morser J; Dole WP; Greaves DR; Deng GG
    J Cell Physiol; 2005 Jul; 204(1):73-82. PubMed ID: 15573379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urokinase plasminogen activator and urokinase plasminogen activator receptor mediate human stem cell tropism to malignant solid tumors.
    Gutova M; Najbauer J; Frank RT; Kendall SE; Gevorgyan A; Metz MZ; Guevorkian M; Edmiston M; Zhao D; Glackin CA; Kim SU; Aboody KS
    Stem Cells; 2008 Jun; 26(6):1406-13. PubMed ID: 18403751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression of urokinase-type plasminogen activator and its receptor in plasma of patients with cerebral infarction].
    Song SJ; Hu JB; Wang HX; Wen SQ; Ding MP; Huang JZ
    Zhonghua Yi Xue Za Zhi; 2003 Sep; 83(18):1583-5. PubMed ID: 14642114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of urokinase-type plasminogen activator and its receptor is up-regulated during tendon healing.
    Xia W; de Bock C; Murrell GA; Wang Y
    J Orthop Res; 2003 Sep; 21(5):819-25. PubMed ID: 12919869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urokinase-receptor-mediated phenotypic changes in vascular smooth muscle cells require the involvement of membrane rafts.
    Kiyan J; Smith G; Haller H; Dumler I
    Biochem J; 2009 Oct; 423(3):343-51. PubMed ID: 19691446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Cross Talk between Neuronal Urokinase-type Plasminogen Activator (uPA) and Astrocytic uPA Receptor (uPAR) Promotes Astrocytic Activation and Synaptic Recovery in the Ischemic Brain.
    Diaz A; Merino P; Manrique LG; Ospina JP; Cheng L; Wu F; Jeanneret V; Yepes M
    J Neurosci; 2017 Oct; 37(43):10310-10322. PubMed ID: 28931568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.
    Hildenbrand R; Schaaf A
    Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue-type plasminogen activator has paradoxical roles in focal cerebral ischemic injury by thrombotic middle cerebral artery occlusion with mild or severe photochemical damage in mice.
    Nagai N; Zhao BQ; Suzuki Y; Ihara H; Urano T; Umemura K
    J Cereb Blood Flow Metab; 2002 Jun; 22(6):648-51. PubMed ID: 12045662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urokinase-type plasminogen activator receptor regulates leukocyte recruitment during experimental pneumococcal meningitis.
    Paul R; Winkler F; Bayerlein I; Popp B; Pfister HW; Koedel U
    J Infect Dis; 2005 Mar; 191(5):776-82. PubMed ID: 15688295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of plasma urokinase-type plasminogen activator and urokinase-type plasminogen-activator receptor in patients with acute and chronic hepatitis B.
    Zhou H; Wu X; Lu X; Chen G; Ye X; Huang J
    Thromb Res; 2009; 123(3):537-42. PubMed ID: 18691743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urokinase-deficient and urokinase receptor-deficient mice have impaired neutrophil antimicrobial activation in vitro.
    Gyetko MR; Aizenberg D; Mayo-Bond L
    J Leukoc Biol; 2004 Sep; 76(3):648-56. PubMed ID: 15240745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initial brain lesion size affects the extent of subsequent pathophysiological responses.
    Nagai N; Kawao N; Okada K; Ishida C; Okumoto K; Ueshima S; Suzuki Y; Umemura K; Matsuo O
    Brain Res; 2010 Mar; 1322():109-17. PubMed ID: 20138161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of growth factors and the urokinase-type plasminogen activator system in pancreatic ductal adenocarcinoma.
    Xue A; Scarlett CJ; Jackson CJ; Allen BJ; Smith RC
    Pancreas; 2008 Mar; 36(2):160-7. PubMed ID: 18376307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation systems for latent matrix metalloproteinase-2 are upregulated immediately after focal cerebral ischemia.
    Chang DI; Hosomi N; Lucero J; Heo JH; Abumiya T; Mazar AP; del Zoppo GJ
    J Cereb Blood Flow Metab; 2003 Dec; 23(12):1408-19. PubMed ID: 14663336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discrimination of different forms of the murine urokinase plasminogen activator receptor on the cell surface using monoclonal antibodies.
    Rasch MG; Pass J; Illemann M; Høyer-Hansen G; Lund IK
    J Immunol Methods; 2008 Nov; 339(1):55-65. PubMed ID: 18761343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevation of mRNA levels of tissue-type plasminogen activator and urokinase-type plasminogen activator in hippocampus and cerebral cortex following middle cerebral artery occlusion in rats.
    Ito T; Takenaka K; Sakai H; Yoshimura S; Hayashi K; Noda S; Sakai N
    Neurol Res; 2000 Jun; 22(4):413-9. PubMed ID: 10874693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urokinase plasminogen activator upregulates paraoxonase 2 expression in macrophages via an NADPH oxidase-dependent mechanism.
    Fuhrman B; Khateeb J; Shiner M; Nitzan O; Karry R; Volkova N; Aviram M
    Arterioscler Thromb Vasc Biol; 2008 Jul; 28(7):1361-7. PubMed ID: 18436804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of urokinase plasminogen activator receptor inhibits proliferation and migration of pancreatic adenocarcinoma cells via regulation of ERK/p38 signaling.
    Xue A; Xue M; Jackson C; Smith RC
    Int J Biochem Cell Biol; 2009; 41(8-9):1731-8. PubMed ID: 19433314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.